|
Matthew S. Eckert
Associate
Emerging Enterprise Center at Foley Hoag (Waltham, MA)
Matt Eckert's business law practice focuses on advising venture capital funds in investments covering a broad range of size and complexity, as well as on assisting emerging companies across the spectrum of development stages in capital-raising activities and mergers and acquisitions. In addition to his extensive work with venture funds and private companies, Matt has substantial experience assisting public companies with securities law compliance, including periodic reporting, securities registration and proxy solicitation. He also counsels clients, both public and private, on other business transactions and general corporate matters. Bars and Court Admissions
Massachusetts
Representative Experience
The following is a brief summary of Matthew's experience and accomplishments:
Advised a gene sequence data provider formerly based in France on its domestication and subsequent U.S.-based venture capital financing
Represented a software company in the sale of its business, valued at over $50 million
Represented a venture capital fund in connection with recapitalization of a Seattle-based venture-backed company specializing in spam filtering software
Represented a venture-backed healthcare data services company in the $31 million sale of its business to on-line healthcare information provider
Represented a venture capital fund in connection with the formation and first-round funding of a Germany-based telecommunications start-up, including the negotiation of a collaboration agreement with and equity issuance to a multi-national engineering firm
Represented a California-based on-line game development studio in an initial $18 million round of venture financing
Represented a large public diagnostic products company in connection with multiple PIPE transactions netting aggregate proceeds in excess of $200 million
Represented a later-stage venture-backed networking company in bridge financing and subsequent complex recapitalization
Represented investors in a $40 million syndicated venture-capital investment in later-stage therapeutics company
professional / civic involvement
American Bar Association, Member
Massachusetts Bar Association, Member
Boston Bar Association, Member.
| 